1.
Prevalence of persistent hypogammaglobulinemia in patients with autoimmune disease receiving rituximab at a national referral center in Mexico. Rev Alerg Mex [Internet]. 2023 Apr. 19 [cited 2026 Sep. 23];69(4):171-82. Available from: https://www.revistaalergia.mx/ojs/index.php/ram/article/view/1142